| Bioactivity | CDK9-IN-31 (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 has the potential to be developed as an anticancer agent[1]. |
| Target | CDK9. |
| Name | CDK9-IN-31 |
| CAS | 2991074-93-0 |
| Formula | C24H33ClN6O2S |
| Molar Mass | 505.08 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fusheng Zhou, et al. CDK9 inhibitor and preparation method and application thereof. Patent CN116496267A. |
CDK9-IN-31
CAS: 2991074-93-0 F: C24H33ClN6O2S W: 505.08
CDK9-IN-31 (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 has the potential to be develo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.